PedAM
Pediatric Disease Annotations & Medicines
| Disease | myocardial infarction |
| Phenotype | |diabetes |
| Sentences | 128 |
| PubMedID- 22247905 | diabetes with no history of myocardial infarction are equally at risk for myocardial infarction as are non-diabetic subjects with a history of myocardial infarction, and they are both classified in the same coronary artery disease risk group [4]. |
| PubMedID- 26180535 | Studies were excluded if (1) animals; (2) review and case report; (3) study focused on specific cad population, for example, female cad patients, acute myocardial infarction, cad with diabetes, and so on (4) duplicate reports. |
| PubMedID- 23593140 | The full models were further adjusted for bmi, smoking (current, former, and never), alcohol consumption (<12, ≥12 drinks in the past year), systolic blood pressure, blood pressure lowing medication, total and hdl cholesterol, diabetes, history of myocardial infarction, history of congestive heart failure, use of qt-prolonging medications, and creatinine-based egfr. |
| PubMedID- 20359353 | Older age, elevated body mass index, higher triglyceride levels, hypercholesterolemia, diabetes, history of myocardial infarction were associated with higher rates of statin use; elevated alkaline phosphatase levels and cmv igg seropositivity were associated with less statin use. |
| PubMedID- 22847458 | An increasing number of elderly people and diabetes patients with myocardial infarction go unrecognized because of painless ischemia and regression of major q-waves over time. |
| PubMedID- 24934236 | Reduced levels of circulating endothelial progenitor cells in acute myocardial infarction patients with diabetes or pre-diabetes: accompanying the glycemic continuum. |
| PubMedID- 23874021 | The first trial, the cardiovascular inflammation reduction trial (cirt), has been funded by the nhlbi and will evaluate whether low-dose methotrexate (target dose, 20 mg/wk) as compared to placebo will reduce major vascular events among a group of post-myocardial infarction patients with either diabetes or metabolic syndrome, groups known to have high risk on the basis of a persistent pro-inflammatory response. |
| PubMedID- 20211319 | In conclusion, an eesbpr was associated with improved survival and a lower rate of death or myocardial infarction in patients with diabetes mellitus and known or suspected cad. |
| PubMedID- 25193670 | Effects of baseline coronary occlusion and diabetes mellitus in patients with st-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. |
| PubMedID- 25300610 | The data observed were: age, sex, diabetes-related complications (annual rates of acute myocardial infarction, major amputations and avoidable hospitalisations), diabetes-related pathologies (prevalence of ischaemic heart disease, renal failure, stroke, heart failure, peripheral neuropathy, foot ulcers and diabetic retinopathy) and other unrelated pathologies (44 diseases). |
| PubMedID- 20843380 | We therefore set out to investigate the association between individual oral glucose-lowering drugs and cardiovascular outcomes following myocardial infarction in patients with diabetes mellitus not treated with emergent percutaneous coronary intervention. |
| PubMedID- 20965878 | diabetes mellitus in patients with myocardial infarction complicated by heart failure: a 'low ejection fraction' equivalent. |
| PubMedID- 20233394 | myocardial infarction for people with diabetes, and vice versa) is controlled for in the logistic regression model (tables 5 and 6). |
| PubMedID- 22182634 | However the prevalence of myocardial infarction was higher in patients with diabetes as a co-morbid condition, although this was possibly due to different age distribution. |
| PubMedID- 23757599 | Previous studies have reported that cimt is increased in children at high risk for cardiovascular disease because of familial hypercholesterolemia, type 1 diabetes, having parents with premature myocardial infarction, or elevated levels of ultrasensitive c-reactive protein compared with other children (jarvisalo et al. |
| PubMedID- 22301118 | Association of coexisting diabetes and depression with mortality after myocardial infarction. |
| PubMedID- 22665216 | Exclusion criteria were type 1 diabetes, history of stroke, myocardial infarction within six months, other clinically important cardiac diseases, arrhythmias, significant nephropathy, kidney or liver transplant, renal or congestive heart failure, carotid artery stenosis (over 50% by medical history and magnetic resonance angiography), and any neurologic or systemic disorders (aside from peripheral neuropathy). |
| PubMedID- 22858312 | Association of manganese superoxide dismutase and glutathione s-transferases genotypes with myocardial infarction in patients with type 2 diabetes mellitus. |
| PubMedID- 26379783 | The exclusion criteria were: type 2 diabetes mellitus, history of myocardial infarction, clinically significant valvular heart disease, chronic kidney disease, chronic liver disease, chronic obstructive pulmonary disease, smoking (>20 cigarettes/day), polytherapy, obstructive sleep apnea. |
| PubMedID- 25887378 | An informed shared decision making programme on the prevention of myocardial infarction for patients with type 2 diabetes in primary care: protocol of a cluster randomised, controlled trial. |
| PubMedID- 20484611 | Recent meta-analyses suggest an increased risk of acute myocardial infarction (ami) in patients with type 2 diabetes mellitus (t2dm) treated with rosiglitazone. |
| PubMedID- 21447495 | Serum resistin in acute myocardial infarction patients with and without diabetes mellitus. |
| PubMedID- 23933608 | Age, killip class, diabetes mellitus, history of stroke and myocardial infarction were independent predictors of death. |
| PubMedID- 25579653 | Age and education, previous and current smoking, systolic blood pressure, hdl cholesterol, type 2 diabetes, family history of myocardial infarction, total cholesterol and use of statins. |
| PubMedID- 26076939 | Improving 30-day case fatality after incident myocardial infarction in people with diabetes between 1998 and 2010. |
| PubMedID- 21193625 | In addition, ace inhibitors have been shown to reduce major cvd outcomes (i.e., myocardial infarction, stroke, death) in patients with diabetes (207), thus further supporting the use of these agents in patients with microalbuminuria, a cvd risk factor. |
| PubMedID- 22963483 | Aims: following myocardial infarction (mi), individuals with diabetes have a two-fold increase in the risk of heart failure, due in part to excessive loss of cardiac microvasculature. |
| PubMedID- 22709128 | In addition to matched variables, the following additional covariates were candidates for adjusted analyses based on clinical significance: diabetes, history of myocardial infarction, history of atrial fibrillation, history of chronic obstructive pulmonary disease, history of chronic liver disease, and systolic blood pressure, heart rate and creatinine clearance preceding readmission for cases or control time period for controls. |